PLGA MS mediated cancer therapy might be an ideal strategy to revert these immunosuppressive mechanisms by inducing factors that are essential for cytotoxicity against cancer cells such as intra-tumoral activated CD8+ T cell response and IFN-γ production as well as recruitment of NK cells. This evidence concerns the gene CD8A and cancer.